The FDA posted the company’s recall announcement on July 9, 2026, as a public-service safety notice. The recalled formula was distributed nationally through Target stores, Target.com and Nara.com.

What the recall covers

The recall covers all lots of Nara Organics powdered infant formula. The stated distribution period ran from July 2025 through June 2026, meaning the affected products may have been available through both retail stores and online purchasing channels over that period.

The FDA’s notice identifies Target and Nara.com as distribution channels. It does not say that all infant formula sold by Target was recalled. The action applies to the Nara Organics powdered infant formula identified in the announcement.

Because the recall is nationwide, the issue is not limited to a particular state or store location. Families who obtained the product through Target stores, Target.com or Nara.com may need to determine whether they have recalled formula and arrange a safe alternative. Retailers and clinicians may also need to help identify affected products and support alternative nutrition arrangements.

What is not yet specified

The available FDA record describes the reason for the action as a possible health risk, but it does not specify the suspected contaminant or explain the precise illness risk. It also does not provide, in the supplied record, lot numbers or details about reported illnesses.

The record does not establish whether every package size was included or whether the recall affected only particular formulations. Those details matter to caregivers trying to determine whether a product in their home is covered, but they are not provided in the approved information available for this report.

The recall should therefore not be described as a confirmed contamination finding. The FDA record supplied for this report supports the existence and scope of the recall and the company’s stated reason—a possible health risk—but does not establish contamination, illnesses or injuries.

Why the notice matters

Infant formula is a critical nutrition product. A nationwide recall can create an immediate identification and access problem for families who depend on formula, particularly when the available notice does not include all of the product-level details needed to distinguish affected items.

The practical impact extends beyond consumers. Retailers may need to identify products connected to the recall, while clinicians and caregivers may need to coordinate safe alternatives. The FDA’s public posting makes the announcement available nationally and places the recall within the agency’s broader system for food, drug and product safety information.

The FDA says its safety-information database distinguishes recalls, public-health alerts and other safety information. The agency also explains that company recall announcements are posted as a public service. In this case, the posted notice records a company recall rather than a separate finding in the supplied material that contamination or illness has been confirmed.

What happens next

The known next step is the public distribution of the recall announcement through the FDA’s safety-information system. The supplied record does not provide a consumer response deadline, a replacement deadline, additional company instructions, a suspected contaminant, lot numbers or a separate report of illnesses.

Until those details are available in the approved record, the central verified facts remain the scope of the action—all lots of Nara Organics powdered infant formula—the possible health-risk rationale, and the national distribution through Target stores, Target.com and Nara.com during the July 2025-to-June 2026 period.